Structural Basis of HIV-1 Neutralization by Affinity Matured Fabs Directed against the Internal Trimeric Coiled-Coil of gp41


The conserved internal trimeric coiled-coil of the N-heptad repeat (N-HR) of HIV-1 gp41 is transiently exposed during the fusion process by forming a pre-hairpin intermediate, thus representing an attractive target for the design of fusion inhibitors and neutralizing antibodies. In previous studies we reported a series of broadly neutralizing mini-antibodies derived from a synthetic naïve human combinatorial antibody library by panning against a mimetic of the trimeric N-HR coiled coil, followed by affinity maturation using targeted diversification of the CDR-H2 loop. Here we report crystal structures of the N-HR mimetic 5-Helix with two Fabs that represent the extremes of this series: Fab 8066 is broadly neutralizing across a wide panel of B and C type HIV-1 viruses, whereas Fab 8062 is non-neutralizing. The crystal structures reveal important differences in the conformations of the CDR-H2 loops in the complexes that propagate into other regions of the antigen-antibody interface, and suggest that both neutralization properties and affinity for the target can be attributed, at least in part, to the differences in the interactions of the CDR-H2 loops with the antigen. Furthermore, modeling of the complex of an N-HR trimer with three Fabs suggests that the CDR-H2 loop may be involved in close intermolecular contacts between neighboring antibody molecules, and that such contacts may hinder the formation of complexes between the N-HR trimer and more than one antibody molecule depending on the conformation of the bound CDR-H2 loop which is defined by its interactions with antigen. Comparison with the crystal structure of the complex of 5-Helix with another neutralizing monoclonal antibody known as D5, derived using an entirely different antibody library and panning procedure, reveals remarkable convergence in the optimal sequence and conformation of the CDR-H2 loop.


Vyšlo v časopise: Structural Basis of HIV-1 Neutralization by Affinity Matured Fabs Directed against the Internal Trimeric Coiled-Coil of gp41. PLoS Pathog 6(11): e32767. doi:10.1371/journal.ppat.1001182
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001182

Souhrn

The conserved internal trimeric coiled-coil of the N-heptad repeat (N-HR) of HIV-1 gp41 is transiently exposed during the fusion process by forming a pre-hairpin intermediate, thus representing an attractive target for the design of fusion inhibitors and neutralizing antibodies. In previous studies we reported a series of broadly neutralizing mini-antibodies derived from a synthetic naïve human combinatorial antibody library by panning against a mimetic of the trimeric N-HR coiled coil, followed by affinity maturation using targeted diversification of the CDR-H2 loop. Here we report crystal structures of the N-HR mimetic 5-Helix with two Fabs that represent the extremes of this series: Fab 8066 is broadly neutralizing across a wide panel of B and C type HIV-1 viruses, whereas Fab 8062 is non-neutralizing. The crystal structures reveal important differences in the conformations of the CDR-H2 loops in the complexes that propagate into other regions of the antigen-antibody interface, and suggest that both neutralization properties and affinity for the target can be attributed, at least in part, to the differences in the interactions of the CDR-H2 loops with the antigen. Furthermore, modeling of the complex of an N-HR trimer with three Fabs suggests that the CDR-H2 loop may be involved in close intermolecular contacts between neighboring antibody molecules, and that such contacts may hinder the formation of complexes between the N-HR trimer and more than one antibody molecule depending on the conformation of the bound CDR-H2 loop which is defined by its interactions with antigen. Comparison with the crystal structure of the complex of 5-Helix with another neutralizing monoclonal antibody known as D5, derived using an entirely different antibody library and panning procedure, reveals remarkable convergence in the optimal sequence and conformation of the CDR-H2 loop.


Zdroje

1. BergerEA

MurphyPM

FarberJM

1999 Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17 657 700

2. EckertDM

KimPS

2001a Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem 70 777 810

3. FurutaRA

WildCT

WengY

WeissCD

1998 Capture of an early fusion-active conformation of HIV-1 gp41. Nature Struct Biol 5 276 279

4. ChanDC

KimPS

1998 HIV entry and its inhibition. Cell 93 681 684

5. MelikyanGB

MarkosyanRM

HemmatiH

DelmedicoMK

LambertDM

2000 Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol 151 413 423

6. GalloSA

FinneganCM

ViardM

RavivY

DimitrovA

2003 The HIV Env-mediated fusion reaction. Biochim Biophys Acta 1614 36 50

7. ChanDC

FassD

BergerJM

KimPS

1997 Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 263 273

8. WeissenhornW

DessenA

HarrisonSC

SkehelJJ

WileyDC

1997 Atomic structure of the ectodomain from HIV-1 gp41. Nature 387 426 430

9. TanK

LiuJ

WangJ

ShenS

LuM

1997 Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A 94 12303 12308

10. CaffreyM

CaiM

KaufmanJ

StahlSJ

WingfieldPT

1998 Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J 17 4572 4584

11. WildC

OasT

McDanalC

BolognesiD

MatthewsT

1992 A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc Natl Acad Sci U S A 89 10537 10541

12. JiangS

LinK

StrickN

NeurathAR

1993 HIV-1 inhibition by a peptide. Nature 365 113

13. WildCT

ShugarsDC

GreenwellTK

McDanalCB

MatthewsTJ

1994 Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci U S A 91 9770 9774

14. EckertDM

MalashkevichVN

HongLH

CarrPA

KimPS

1999 Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket. Cell 99 103 115

15. RootMJ

KayMS

KimPS

2001 Protein design of an HIV-1 entry inhibitor. Science 291 884 888

16. LouisJM

BewleyCA

CloreGM

2001 Design and properties of NCCG-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity. J Biol Chem 276 29485 29489

17. ZwickMB

LabrijnAF

WangM

SpenlehauerC

SaphireEO

2001 Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41. J Virol 75 10892 10905

18. EckertDM

KimPS

2001b Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region. Proc Natl Acad Sci U S A 98 11187 11192

19. BewleyCA

LouisJM

GhirlandoR

CloreGM

2002 Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41. J Biol Chem 277 14238 14245

20. GoldingH

ZaitsevaM

de RosnyE

KingLR

ManischewitzJ

2002 Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. J Virol 76 6780 6790

21. LouisJM

NesheiwatI

ChangL

CloreGM

BewleyCA

2003 Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion. J Biol Chem 278 20278 20285

22. RootMJ

StegerHK

2004 HIV-1 gp41 as a target for viral entry inhibition. Curr Pharm Des 10 1805 1825

23. MatthewsT

SalgoM

GreenbergM

ChungJ

DeMasiR

2004 Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes. Nature Rev Drug Discov 3 215 225

24. LouisJM

BewleyCA

GustchinaE

AnianaA

CloreGM

2005 Characterization and HIV-1 fusion inhibitory properties of monoclonal Fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41. J Mol Biol 353 945 951

25. GustchinaE

HummerG

BewleyCA

CloreGM

2005 Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV. J Med Chem 48 3036 3044

26. GustchinaE

LouisJM

BewleyCA

CloreGM

2006 Synergistic inhibition of HIV-1 envelope-mediated membrane fusion by inhibitors targeting the N and C-terminal heptad repeats of gp41. J Mol Biol 364 283 289

27. StegerHK

RootMJ

2006 Kinetic dependence to HIV-1 entry inhibition. J Biol Chem 281 25813 25821

28. EckertDM

ShiY

KimS

WelchBD

KangE

2008 Characterization of the steric defense of the HIV-1 gp41 N-trimer region. Protein Sci 17 2091 2100

29. GustchinaE

BewleyCA

CloreGM

2008 Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41. J Virol 82 10032 10041

30. HrinR

MontgomeryDL

WangF

CondraJH

AnZ

2008 Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41. AIDS Res Hum Retroviruses 24 1537 1544

31. KahleKM

StegerHK

RootMJ

2009 Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor binding. PLoS Pathog 5 e1000674

32. BianchiE

JoyceJG

MillerMD

FinnefrockAC

LiangX

(Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates. Proc Natl Acad Sci U S A 107 10655 10660

33. CortiD

LangedijkJP

HinzA

SeamanMS

VanzettaF

(Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One 5 e8805

34. MillerMD

GeleziunasR

BianchiE

LennardS

HrinR

2005 A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. Proc Natl Acad Sci U S A 102 14759 14764

35. GustchinaE

LouisJM

LamSN

BewleyCA

CloreGM

2007 A Monoclonal Fab Derived From a Human Non-Immune Phage Library Reveals a New Epitope on gp41 and Neutralizes Diverse HIV-1 Strains. J Virol 81 12946 12953

36. ChoudhryV

ZhangMY

SidorovIA

LouisJM

HarrisI

2007 Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology 363 79 90

37. ZhangMY

VuBK

ChoudharyA

LuH

HumbertM

2008 Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens. J Virol 82 6869 6879

38. NelsonJD

KinkeadH

BrunelFM

LeamanD

JensenR

2008 Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. Virology 377 170 183

39. GustchinaE

LouisJM

FrischC

YleraF

LechnerA

2009 Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naive human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth. Virology 393 112 119

40. MontgomeryDL

WangYJ

HrinR

LuftigM

SuB

2009 Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41. MAbs 1 462 474

41. LuftigMA

MattuM

Di GiovineP

GeleziunasR

HrinR

2006 Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. Nature Struct Mol Biol 13 740 747

42. RotheC

UrlingerS

LohningC

PrasslerJ

StarkY

2008 The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. J Mol Biol 376 1182 1200

43. ReynoldsC

DamerellD

JonesS

2009 ProtorP: a protein-protein interaction analysis server. Bioinformatics 25 413 414

44. KuikenC

FoleyB

MarxP

WolinskyS

LeitnerT

2009 HIV Sequence Compendium 2009. Los Alamos Theoretical Biology and Biophysics Group, Los Alamos National Laboratory 352 359

45. HuntDF

YatesJR3rd

ShabanowitzJ

WinstonS

HauerCR

1986 Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci U S A 83 6233 6237

46. ShevchenkoA

WilmM

VormO

MannM

1996 Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68 850 858

47. YuYQ

GilarM

LeePJ

BouvierES

GeblerJC

2003 Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins. Anal Chem 75 6023 6028

48. McCoyAJ

Grosse-KunstleveRW

AdamsPD

WinnMD

StoroniLC

2007 Phaser crystallographic software. J Appl Crystallogr 40 658 674

49. MurshudovGN

VaginAA

DodsonEJ

1997 Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53 240 255

50. EmsleyP

CowtanK

2004 Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60 2126 2132

51. ChothiaC

LeskAM

1987 Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 196 901 917

52. KuszewskiJ

GronenbornAM

CloreGM

1999 Improving the packing and accuracy of NMR structures with a pseudopotential for the radius of gyration. J Am Chem soc 121 2337 2338

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa